UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 47

Sortiert nach

Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update

Clinical pharmacology and therapeutics, 2017-07, Vol.102 (1), p.37-44

2017

Volltextzugriff (PDF)

Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants

Clinical pharmacology and therapeutics, 2013-05, Vol.93 (5), p.402-408

2013

Volltextzugriff (PDF)

Endothelial nitric oxide synthetase genetic variants, metabolic syndrome and endothelial function in schizophrenia

Journal of psychopharmacology (Oxford), 2014-04, Vol.28 (4), p.349-356

2014

Volltextzugriff (PDF)

Aberrant Brain Signal Variability and COMT Genotype in Chronic TMD Patients

Journal of dental research, 2021-07, Vol.100 (7), p.714-722

2021

Volltextzugriff (PDF)

Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update

Clinical pharmacology and therapeutics, 2017-07, Vol.102 (1), p.37-44

2017

Volltextzugriff (PDF)

µ-Opioid Activity in Chronic TMD Pain Is Associated with COMT Polymorphism

Journal of dental research, 2019-11, Vol.98 (12), p.1324-1331

2019

Volltextzugriff (PDF)

The influence of metabolic syndrome, physical activity and genotype on catechol-O-methyl transferase promoter-region methylation in schizophrenia

The pharmacogenomics journal, 2013-06, Vol.13 (3), p.264-271

2013

Volltextzugriff (PDF)

Pooled Analysis of Antidepressant Levels in Lactating Mothers, Breast Milk, and Nursing Infants

The American journal of psychiatry, 2004-06, Vol.161 (6), p.1066-1078

2004

Volltextzugriff (PDF)

IL-6 is associated with metabolic syndrome in bipolar disorder

Brain, behavior, and immunity, 2010, Vol.24, p.S47-S47

2010

Volltextzugriff (PDF)

The Influence of the Brain-Derived Neurotropic Factor Val66Met -Genotype and HMG-CoA Reductase Inhibitors on Insulin Resistance in the Schizophrenia and Bipolar Populations

Clinical and translational science, 2012-12, Vol.5 (6), p.486-490

2012

Volltextzugriff (PDF)

Risk factors associated with metabolic syndrome in bipolar and schizophrenia subjects treated with antipsychotics: the role of folate pharmacogenetics

Journal of clinical psychopharmacology, 2012-04, Vol.32 (2), p.261-265

2012

Volltextzugriff (PDF)

Venlafaxine: a heterocyclic antidepressant

American journal of hospital pharmacy, 1994-12, Vol.51 (24), p.3033

1994

Volltextzugriff (PDF)

Abnormal Movements and Tardive Dyskinesia in Smokers and Nonsmokers with Schizophrenia Genotyped for Cytochrome P450 2D6

Pharmacotherapy, 2002-11, Vol.22 (11), p.1416-1419

2002

Volltextzugriff (PDF)

Pharmacotherapy of Primary Obsessive-Compulsive Disorder: Review of the Literature

Pharmacotherapy, 1998-09, Vol.18 (5), p.936-960

Ellingrod, Vicki L.

1998

Volltextzugriff (PDF)

Nefazodone: a new antidepressant

American journal of health-system pharmacy, 1995-12, Vol.52 (24), p.2799

1995

Volltextzugriff (PDF)

Leptin gene -2548G/A variants predict risperidone-associated weight gain in children and adolescents

Psychiatric genetics, 2009-12, Vol.19 (6), p.320-327

2009

Volltextzugriff (PDF)

Pharmacogenetic screening for susceptibility to fetal malformations in women

The Annals of pharmacotherapy, 2000-05, Vol.34 (5), p.639

2000

Volltextzugriff (PDF)

Lack of menstrual cycle effects on hypothalamic‐ pituitary‐adrenal axis response to insulin‐induced hypoglycaemia

Clinical endocrinology (Oxford), 2000-06, Vol.52 (6), p.781-787

2000

Volltextzugriff (PDF)

Comparison of Risperidone with Olanzapine in Elderly Patients with Dementia and Psychosis

Pharmacotherapy, 2002-01, Vol.22 (1), p.1-5

2002

Volltextzugriff (PDF)

Association between cytochrome P4502D6 (CYP2D6) genotype, antipsychotic exposure, and abnormal involuntary movement scale (AIMS) score

Psychiatric genetics, 2000-03, Vol.10 (1), p.9-11

2000

Volltextzugriff (PDF)

Association between the polymorphic GRM3 gene and negative symptom improvement during olanzapine treatment

Schizophrenia research, 2005-09, Vol.77 (2), p.253-260

2005

Volltextzugriff (PDF)

Clozapine-induced weight gain associated with the 5HT2C receptor −759C/T polymorphism

American journal of medical genetics. Part B, Neuropsychiatric genetics, 2005-02, Vol.133B (1), p.97-100

2005

Volltextzugriff (PDF)

Psychosexual effects of three doses of testosterone cycling in normal men

Biological psychiatry (1969), 1999-02, Vol.45 (3), p.254-260

1999

Volltextzugriff (PDF)

The association between risk factors for tardive dyskinesia and phenylalanine-induced abnormal movements in schizophrenia

Human psychopharmacology, 2001-04, Vol.16 (3), p.273-277

2001

Volltextzugriff (PDF)

The Effects of Anabolic Steroids on Driving Performance as Assessed by the Iowa Driver Simulator

The American journal of drug and alcohol abuse, 1997-01, Vol.23 (4), p.623-636

1997

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(47)

Sprache

Englisch
(47)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(40)
Science & Technology
(40)
Humans
(37)
Male
(22)
Pharmacology & Pharmacy
(21)
Female
(20)
Adult
(18)
Biological And Medical Sciences
(16)
Medical Sciences
(15)
Psychiatry
(13)
Middle Aged
(12)
Pharmacology. Drug Treatments
(12)
Genotype
(11)
Schizophrenia - Drug Therapy
(10)
Schizophrenia
(9)
Antipsychotic Agents - Therapeutic Use
(8)
Neurosciences & Neurology
(8)
Pharmacogenetics
(8)
Psychology. Psychoanalysis. Psychiatry
(8)
Schizophrenia - Genetics
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update

Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants

Endothelial nitric oxide synthetase genetic variants, metabolic syndrome and endothelial function in schizophrenia

Aberrant Brain Signal Variability and COMT Genotype in Chronic TMD Patients

Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update

µ-Opioid Activity in Chronic TMD Pain Is Associated with COMT Polymorphism

The influence of metabolic syndrome, physical activity and genotype on catechol-O-methyl transferase promoter-region methylation in schizophrenia

Pooled Analysis of Antidepressant Levels in Lactating Mothers, Breast Milk, and Nursing Infants

IL-6 is associated with metabolic syndrome in bipolar disorder

The Influence of the Brain-Derived Neurotropic Factor Val66Met -Genotype and HMG-CoA Reductase Inhibitors on Insulin Resistance in the Schizophrenia and Bipolar Populations

Risk factors associated with metabolic syndrome in bipolar and schizophrenia subjects treated with antipsychotics: the role of folate pharmacogenetics

Venlafaxine: a heterocyclic antidepressant

Abnormal Movements and Tardive Dyskinesia in Smokers and Nonsmokers with Schizophrenia Genotyped for Cytochrome P450 2D6

Pharmacotherapy of Primary Obsessive-Compulsive Disorder: Review of the Literature

Nefazodone: a new antidepressant

Leptin gene -2548G/A variants predict risperidone-associated weight gain in children and adolescents

Pharmacogenetic screening for susceptibility to fetal malformations in women

Lack of menstrual cycle effects on hypothalamic‐ pituitary‐adrenal axis response to insulin‐induced hypoglycaemia

Comparison of Risperidone with Olanzapine in Elderly Patients with Dementia and Psychosis

Association between cytochrome P4502D6 (CYP2D6) genotype, antipsychotic exposure, and abnormal involuntary movement scale (AIMS) score

Association between the polymorphic GRM3 gene and negative symptom improvement during olanzapine treatment

Clozapine-induced weight gain associated with the 5HT2C receptor −759C/T polymorphism

Psychosexual effects of three doses of testosterone cycling in normal men

The association between risk factors for tardive dyskinesia and phenylalanine-induced abnormal movements in schizophrenia

The Effects of Anabolic Steroids on Driving Performance as Assessed by the Iowa Driver Simulator

Suchergebnisse filtern